nsclc

The clinical manifestations and chest imaging of PSC were similar to that of other types of non small cell lung carcinomas (NSCLC).

Thoracic radiotherapy has been a key component of local treatment for the patients with non small cell lung cancer(NSCLC).

Due to the lack of the valid diagnosis methods of the early-onset lung cancer, unfortunately most patients were diagnosed at late stage.

Conclusion: chemotherapy combined with Thymosin on post-operative patients of NSCLC can reduce the side effects of chemotherapy.

Palliative surgery should be a part of multidisciplinary therapy for selective patients with advanced NSCLC.

It indicates that international pharmaceutical companies can take advantages of the resources available to develop more medicines for NSCLC.

The methods used to identify disease distribution are the same for NSCLC and SCLC.

None of the htSNP was associated with NSCLC risk in anyone of two case-control studies.

A total of 2281 patients with NSCLC were screened for EGFR mutations in their tumors and, of this group, 327 had mutations.

Many studies showed that DNA methylation is specific marker of NSCLC in its diagnosis, staging, treatment and prognosis.

COX multivariate survival analysis: TNM stage, PTEN and Ezrin expression is an independent prognostic risk factors in NSCLC patients (p05).

This article summarized the latest developments in chemotherapy and molecular targeted therapy of non-small cell lung cancer.

Objective To evaluate the clinical effect and toxicity of pemetrexed in treating elder advanced non. small cell lung cancer(NSCLC).

Objective To investigate the economic effects of three chemotherapy schemes in the treatment of non- small cell lung cancer (NSCLC).

What proportion of your NSCLC patients would you conduct this test?

The treatment options and associated mortality for NSCLC change dramatically with each stage.

However, little was known about connection between inactivation of the TGFBR1 gene and the presence of CpG methylated promoter in NSCLC.

These data demonstrate that H-REV107-1 exerts pro-growth functions within a subset of NSCLC cells in a location-dependent manner.

Methods: Ar-He knife was used combined with chemotherapy of allied two medicines containing Pt to treat NSCLC.

The main pathology type is small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC).

The results were confirmed using two additional adenocarcinoma NSCLC and two nonadenocarcinoma NSCLC cell lines.

Conclusion CCR7 could induce lymphangiogenesis and promote lymph node metastasis by up regulating the expression of VEGF-D in NSCLC.

Objective To observe the toxicity of shenqifuzheng injection combined with NP regimen in the treatment of non-small cell lung cancer(NSCLC).

Objective To observe the difference of sensitiveness of non-small-cell lung cancer(NSCLC) to neoadjuvant chemotherapy(NACT).

The incidence of adverse thrombotic events was higher in the advanced NSCLC group than in the non-advanced NSCLC group.

Which statements would you choose to further develop your "story" to encompass the usage of Iressa in 2nd line treatment of advanced NSCLC?

Methods The clinical data of 18 patients with NSCLC and solitary brain metastasis were retrospectively analysed.

In retrospect of advances in target therapy of NSCLC, many problems remained to answer.

Afatinib is under development in several solid tumors including non-small cell lung cancer (NSCLC) and head and neck cancer.

Objective: To observe the curative effect and adverse event of non-small cell lung cancer(NSCLC) patients who took ZD1839.

Conclusion AD injection in combination with 3D-CRT can enhance the efficacy of elderly patients with NSCLC.

Results Heparanase was highly expressed in lung cancer tissues (74. 2%) while negative in epithelia of normal lung tissues.

Objective To investigate the significances of telomerase activity and P53 expression in Non-small cell lung cancer (NSCLC).

Conclusions: CYFRA21-1 is a very valuable marker to diagnose pulmonary carcinoma (especially NSCLC) and to estimate the effect of treatment.

Past, Present and Future of Targeted Therapy in NSCLC.

Based on what you read, how likely would you be to use IRESSA as 1st line treatment in advanced NSCLC in your patients?

Methods 70 cases of NSCLC were randomly divided into two groups (NVB group and VDS group)and treated with NP or MVP regimen.

We developed a five-gene signature that is closely associated with survival of patients with NSCLC.

Results The expression of VEGF was significantly higher in NSCLC than that in normal tissue around the cancer (P01).

AIM: To study the efficiency and toxicities of docetaxel gemcitabine combination on advanced non small cell lung cancer (NSCLC).

Telomerase catalytic sub-unit expression and its relation with that of c-myc gene in human NSCLC tissues

Objective: To study the nursing methods in the treatment of NSCLC by cryosurgery(Ar-He knife) combined with chemotherapy.

Cost effectiveness analysis and clinical evaluation of pharmacoepidemiology of four combination chemotherapy of NSCLC

Clinical study on radiofrequency-capacitive regional hyperthermia combined with chemotherapy by GP scheme for treatment of advanced NSCLC

Clinic investigation of involved-field irradiation in three-dimensional conformal radiation for old patients of advanced NSCLC

Clinical study of BCG-PSN combined with operation or chemotherapy in treating NSCLC

Clinical Observation of Domestic Nedaplatin Combination Chemotherapy in Advanced NSCLC

Clinic comparative study of TP and EP chemotherapy for advanced NSCLC cancer

Synchronia bronchial and pulmonary arterial sleeve resection and reconstruction in the treatment of central NSCLC

Radiofrequency Ablation Versus Chemotherapy in Advanced NSCLC: A Comparison Study

Observe on the Effects Vinorelbine Combined with Cisplatin for the Treatment of Advanced NSCLC

CT-guided percutaneous puncturing implant with Cisplatin sustained release in treatment of NSCLC

Bronchial and pulmonary arterial sleeve resection and reconstruction in the treatment of central NSCLC

Peripheral Blood Cell Analyze and Their Relationship with Prognosis of Advanced NSCLC Patients

Correlation of pathological types and clinical stages of NSCLC with the blood telomerase activity

Clinical effect and side reactions of elderly patients with advanced NSCLC by gemcitabine with cisplatin

A Clinical Study on Direct intervenient Therapy with Percutaneous Lung Puncture for Advanced NSCLC

Bronchoplasty and Pulmonary Artery Reconstruction in the Treatment for Central NSCLC

The Clinical Significance of Detection of EGFRmRNA Expressions in Peripheral Venous Blood of the Patients with NSCLC

Study on influencing prognostic factors of surgical treatment in elderly patients with NSCLC

Clinical observation of advanced NSCLC in the aged treated by gemcitabine combined with cisplatin

Preliminary Report of GP-T in Treatment of the NSCLC Patients with Metastatic Brain Tumor

Consistency and controversy of surgical treatment on locally advanced NSCLC

Circulating endothelial cells in the peripheral blood of advanced NSCLC patients

The Isolation, Culture and Identification of Dendritic Cells Derived from EMPE in NSCLC

Influence of some factors on the relapse metastasis and survival of the postoperative stage I NSCLC

Research of Chinese Traditional Medicine's Synergism on Chemotherapy of NSCLC

A study on the relationship between serum level of VEGF and its expression in tumor tissue of NSCLC

The Applications of Bio therapy and Chemotherapy in the Multi modality Treatment of NSCLC

Surgical treatment of locally advanced NSCLC invading left atrium

Clinical Research on The Technique of Sentinel Lymph Node Biopsy in Patients with NSCLC

Clinical Significance of Serum Tumor Markers Level in Patients with NSCLC

Study on Pharmacodynamics of High-Dose Tamoxifen in NSCLC Patients

Assessment of response status in advanced NSCLC by Cox analysis

Anti-CK-19 and Its Use in the Detection of Micrometastasis to Lymph Nodes of NSCLC

Clinical study on advanced NSCLC treated by combining chemotherapy based on gemcitabine

Clinical study on diyushengbai tablet to prevent blood cell reduction of NSCLC patients with chemotherapy

Expression of ERCC-1 in NSCLC tissue and its value for appraising chemotherapy

Study on the Expression of BI-1 and Relative Regulators in Human NSCLC Cell Lines

Comparison two kinds of projects treatment of patients with advanced NSCLC

Therapeutic effect of VDS regimen on 80 cases of NSCLC